Sorrento Therapeutics, Inc.
Insider CIK 850261 · CELU 10% owner · SCLX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CELU Celularity Inc | S Sale | 2023-10-05 | 2023-10-05 | 6,307,158 | — | $0 | 5,050,427 | SEC↗ |
| CELU Celularity Inc | S Sale | 2023-09-29 | 2023-10-05 | 9,064,539 | — | $0 | 11,357,585 | SEC↗ |
| SCLX Scilex Holding Co | S Sale deriv | 2023-09-21 | 2023-09-25 | 4,490,617 | — | $0 | 0 | SEC↗ |
| SCLX Scilex Holding Co | S Sale | 2023-09-21 | 2023-09-25 | 60,068,585 | — | $0 | 1,917,210 | SEC↗ |
| SCLX Scilex Holding Co | J Other | 2023-01-19 | 2023-01-23 | 73,740,795 | — | $0 | 61,985,795 | SEC↗ |
| SCLX Scilex Holding Co | P Buy deriv | 2022-12-02 | 2022-12-02 | 224,841 | $0.35 | $78.7K | 4,490,617 | SEC↗ |
| SCLX Scilex Holding Company/DE | P Buy deriv | 2022-11-25 | 2022-11-25 | 46,172 | $0.44 | $20.3K | 4,265,776 | SEC↗ |
| SCLX Scilex Holding Company/DE | P Buy deriv | 2022-11-23 | 2022-11-23 | 442,829 | $0.40 | $177.1K | 4,219,604 | SEC↗ |
| SCLX Scilex Holding Company/DE | P Buy deriv | 2022-11-22 | 2022-11-22 | 672,775 | $0.23 | $154.7K | 3,776,775 | SEC↗ |
| SCLX Vickers Vantage Corp. I | J Other deriv | 2022-11-10 | 2022-11-15 | 307,296 | — | $0 | 3,104,000 | SEC↗ |
| SCLX Vickers Vantage Corp. I | J Other deriv | 2022-11-10 | 2022-11-15 | 2,796,704 | — | $0 | 2,796,704 | SEC↗ |